Global Human Cytomegalovirus Envelope Glycoprotein B Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Human Cytomegalovirus Envelope Glycoprotein B market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Human Cytomegalovirus Envelope Glycoprotein B players cover Astellas Pharma Inc., Trellis Bioscience, Inc., Vakzine Projekt Management GmbH, VBI Vaccine Inc, Vical Incorporated, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Human Cytomegalovirus Envelope Glycoprotein B Industry Forecast” looks at past sales and reviews total world Human Cytomegalovirus Envelope Glycoprotein B sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Cytomegalovirus Envelope Glycoprotein B sales for 2025 through 2031. With Human Cytomegalovirus Envelope Glycoprotein B sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Cytomegalovirus Envelope Glycoprotein B industry.
This Insight Report provides a comprehensive analysis of the global Human Cytomegalovirus Envelope Glycoprotein B landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Cytomegalovirus Envelope Glycoprotein B portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Cytomegalovirus Envelope Glycoprotein B market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Cytomegalovirus Envelope Glycoprotein B and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Cytomegalovirus Envelope Glycoprotein B.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Cytomegalovirus Envelope Glycoprotein B market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Human Cytomegalovirus Envelope Glycoprotein B market?
What factors are driving Human Cytomegalovirus Envelope Glycoprotein B market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Cytomegalovirus Envelope Glycoprotein B market opportunities vary by end market size?
How does Human Cytomegalovirus Envelope Glycoprotein B break out by Type, by Application?
The global Human Cytomegalovirus Envelope Glycoprotein B market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Human Cytomegalovirus Envelope Glycoprotein B players cover Astellas Pharma Inc., Trellis Bioscience, Inc., Vakzine Projekt Management GmbH, VBI Vaccine Inc, Vical Incorporated, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Human Cytomegalovirus Envelope Glycoprotein B Industry Forecast” looks at past sales and reviews total world Human Cytomegalovirus Envelope Glycoprotein B sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Cytomegalovirus Envelope Glycoprotein B sales for 2025 through 2031. With Human Cytomegalovirus Envelope Glycoprotein B sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Cytomegalovirus Envelope Glycoprotein B industry.
This Insight Report provides a comprehensive analysis of the global Human Cytomegalovirus Envelope Glycoprotein B landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Cytomegalovirus Envelope Glycoprotein B portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Cytomegalovirus Envelope Glycoprotein B market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Cytomegalovirus Envelope Glycoprotein B and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Cytomegalovirus Envelope Glycoprotein B.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Cytomegalovirus Envelope Glycoprotein B market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- CSJ-148
- CyMVectin
- TRL-345
- PPCM
- Cytomegalovirus Vaccine
- Others
- Infectious Disease
- Oncology
- Women's Health
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Astellas Pharma Inc.
- Trellis Bioscience, Inc.
- Vakzine Projekt Management GmbH
- VBI Vaccine Inc
- Vical Incorporated
What is the 10-year outlook for the global Human Cytomegalovirus Envelope Glycoprotein B market?
What factors are driving Human Cytomegalovirus Envelope Glycoprotein B market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Cytomegalovirus Envelope Glycoprotein B market opportunities vary by end market size?
How does Human Cytomegalovirus Envelope Glycoprotein B break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Cytomegalovirus Envelope Glycoprotein B by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Cytomegalovirus Envelope Glycoprotein B by Country/Region, 2020, 2024 & 2031
2.2 Human Cytomegalovirus Envelope Glycoprotein B Segment by Type
2.2.1 CSJ-148
2.2.2 CyMVectin
2.2.3 TRL-345
2.2.4 PPCM
2.2.5 Cytomegalovirus Vaccine
2.2.6 Others
2.3 Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
2.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2020-2025)
2.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Type (2020-2025)
2.4 Human Cytomegalovirus Envelope Glycoprotein B Segment by Application
2.4.1 Infectious Disease
2.4.2 Oncology
2.4.3 Women's Health
2.4.4 Others
2.5 Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
2.5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Market Share by Application (2020-2025)
2.5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Breakdown Data by Company
3.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Company (2020-2025)
3.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2020-2025)
3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Company (2020-2025)
3.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Company (2020-2025)
3.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company (2020-2025)
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Company
3.4 Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Location Distribution
3.4.2 Players Human Cytomegalovirus Envelope Glycoprotein B Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B BY GEOGRAPHIC REGION
4.1 World Historic Human Cytomegalovirus Envelope Glycoprotein B Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country/Region (2020-2025)
4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
4.4 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
4.5 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
4.6 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
5 AMERICAS
5.1 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
5.1.1 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025)
5.1.2 Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025)
5.2 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2020-2025)
5.3 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
6.1.1 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2025)
6.1.2 APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2020-2025)
6.2 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2020-2025)
6.3 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Cytomegalovirus Envelope Glycoprotein B by Country
7.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025)
7.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025)
7.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2020-2025)
7.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B by Country
8.1.1 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2020-2025)
8.3 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B
10.3 Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
10.4 Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors
11.3 Human Cytomegalovirus Envelope Glycoprotein B Customer
12 WORLD FORECAST REVIEW FOR HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B BY GEOGRAPHIC REGION
12.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Region
12.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Region (2026-2031)
12.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Type (2026-2031)
12.7 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Astellas Pharma Inc.
13.1.1 Astellas Pharma Inc. Company Information
13.1.2 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Astellas Pharma Inc. Main Business Overview
13.1.5 Astellas Pharma Inc. Latest Developments
13.2 Trellis Bioscience, Inc.
13.2.1 Trellis Bioscience, Inc. Company Information
13.2.2 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Trellis Bioscience, Inc. Main Business Overview
13.2.5 Trellis Bioscience, Inc. Latest Developments
13.3 Vakzine Projekt Management GmbH
13.3.1 Vakzine Projekt Management GmbH Company Information
13.3.2 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Vakzine Projekt Management GmbH Main Business Overview
13.3.5 Vakzine Projekt Management GmbH Latest Developments
13.4 VBI Vaccine Inc
13.4.1 VBI Vaccine Inc Company Information
13.4.2 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 VBI Vaccine Inc Main Business Overview
13.4.5 VBI Vaccine Inc Latest Developments
13.5 Vical Incorporated
13.5.1 Vical Incorporated Company Information
13.5.2 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Vical Incorporated Main Business Overview
13.5.5 Vical Incorporated Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Human Cytomegalovirus Envelope Glycoprotein B Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Cytomegalovirus Envelope Glycoprotein B Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CSJ-148
Table 4. Major Players of CyMVectin
Table 5. Major Players ofTRL-345
Table 6. Major Players of PPCM
Table 7. Major Players of Cytomegalovirus Vaccine
Table 8. Major Players of Others
Table 9. Global Human Cytomegalovirus Envelope Glycoprotein B Sales byType (2020-2025) & (K Pcs)
Table 10. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share byType (2020-2025)
Table 11. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue byType (2020-2025) & ($ million)
Table 12. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share byType (2020-2025)
Table 13. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price byType (2020-2025) & (USD/Pcs)
Table 14. Global Human Cytomegalovirus Envelope Glycoprotein B Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Market Share by Application (2020-2025)
Table 16. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2020-2025) & ($ million)
Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2020-2025)
Table 18. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2020-2025)
Table 21. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company (2020-2025)
Table 23. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Producing Area Distribution and Sales Area
Table 25. Players Human Cytomegalovirus Envelope Glycoprotein B Products Offered
Table 26. Human Cytomegalovirus Envelope Glycoprotein B Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Geographic Region (2020-2025)
Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country/Region (2020-2025)
Table 35. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2020-2025)
Table 39. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales byType (2020-2025) & (K Pcs)
Table 41. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2020-2025)
Table 44. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales byType (2020-2025) & (K Pcs)
Table 46. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales byType (2020-2025) & (K Pcs)
Table 50. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales byType (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Human Cytomegalovirus Envelope Glycoprotein B
Table 56. Key Market Challenges & Risks of Human Cytomegalovirus Envelope Glycoprotein B
Table 57. Key IndustryTrends of Human Cytomegalovirus Envelope Glycoprotein B
Table 58. Human Cytomegalovirus Envelope Glycoprotein B Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Human Cytomegalovirus Envelope Glycoprotein B Distributors List
Table 61. Human Cytomegalovirus Envelope Glycoprotein B Customer List
Table 62. Global Human Cytomegalovirus Envelope Glycoprotein B SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. Global Human Cytomegalovirus Envelope Glycoprotein B RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Americas Human Cytomegalovirus Envelope Glycoprotein B SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Human Cytomegalovirus Envelope Glycoprotein B Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. APAC Human Cytomegalovirus Envelope Glycoprotein B SalesForecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Human Cytomegalovirus Envelope Glycoprotein B Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 68. Europe Human Cytomegalovirus Envelope Glycoprotein B SalesForecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Human Cytomegalovirus Envelope Glycoprotein B RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B SalesForecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B RevenueForecast by Country (2026-2031) & ($ millions)
Table 72. Global Human Cytomegalovirus Envelope Glycoprotein B SalesForecast byType (2026-2031) & (K Pcs)
Table 73. Global Human Cytomegalovirus Envelope Glycoprotein B RevenueForecast byType (2026-2031) & ($ millions)
Table 74. Global Human Cytomegalovirus Envelope Glycoprotein B SalesForecast by Application (2026-2031) & (K Pcs)
Table 75. Global Human Cytomegalovirus Envelope Glycoprotein B RevenueForecast by Application (2026-2031) & ($ millions)
Table 76. Astellas Pharma Inc. Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 77. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 78. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. Astellas Pharma Inc. Main Business
Table 80. Astellas Pharma Inc. Latest Developments
Table 81.Trellis Bioscience, Inc. Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 82.Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 83.Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84.Trellis Bioscience, Inc. Main Business
Table 85.Trellis Bioscience, Inc. Latest Developments
Table 86. Vakzine Projekt Management GmbH Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 87. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 88. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. Vakzine Projekt Management GmbH Main Business
Table 90. Vakzine Projekt Management GmbH Latest Developments
Table 91. VBI Vaccine Inc Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 92. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 93. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. VBI Vaccine Inc Main Business
Table 95. VBI Vaccine Inc Latest Developments
Table 96. Vical Incorporated Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 97. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 98. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99. Vical Incorporated Main Business
Table 100. Vical Incorporated Latest Developments
LIST OFFIGURES
Figure 1. Picture of Human Cytomegalovirus Envelope Glycoprotein B
Figure 2. Human Cytomegalovirus Envelope Glycoprotein B Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Cytomegalovirus Envelope Glycoprotein B Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country/Region (2024)
Figure 10. Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of CSJ-148
Figure 12. Product Picture of CyMVectin
Figure 13. Product Picture ofTRL-345
Figure 14. Product Picture of PPCM
Figure 15. Product Picture of Cytomegalovirus Vaccine
Figure 16. Product Picture of Others
Figure 17. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share byType in 2025
Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share byType (2020-2025)
Figure 19. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Infectious Disease
Figure 20. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Infectious Disease (2020-2025) & (K Pcs)
Figure 21. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Oncology
Figure 22. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Oncology (2020-2025) & (K Pcs)
Figure 23. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Women's Health
Figure 24. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Women's Health (2020-2025) & (K Pcs)
Figure 25. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Others
Figure 26. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Others (2020-2025) & (K Pcs)
Figure 27. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Market Share by Application (2024)
Figure 28. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application in 2025
Figure 29. Human Cytomegalovirus Envelope Glycoprotein B Sales by Company in 2025 (K Pcs)
Figure 30. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company in 2025
Figure 31. Human Cytomegalovirus Envelope Glycoprotein B Revenue by Company in 2025 ($ millions)
Figure 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company in 2025
Figure 33. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales 2020-2025 (K Pcs)
Figure 36. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue 2020-2025 ($ millions)
Figure 37. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales 2020-2025 (K Pcs)
Figure 38. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue 2020-2025 ($ millions)
Figure 39. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales 2020-2025 (K Pcs)
Figure 40. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales 2020-2025 (K Pcs)
Figure 42. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue 2020-2025 ($ millions)
Figure 43. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2025
Figure 44. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2020-2025)
Figure 45. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share byType (2020-2025)
Figure 46. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
Figure 47. United States Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region in 2025
Figure 52. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2020-2025)
Figure 53. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share byType (2020-2025)
Figure 54. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
Figure 55. China Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 59. India Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 61. ChinaTaiwan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2025
Figure 63. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2020-2025)
Figure 64. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share byType (2020-2025)
Figure 65. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
Figure 66. Germany Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 67.France Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share byType (2020-2025)
Figure 73. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
Figure 74. Egypt Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 77.Turkey Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B in 2025
Figure 80. Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
Figure 81. Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B
Figure 82. Channels of Distribution
Figure 83. Global Human Cytomegalovirus Envelope Glycoprotein B Sales MarketForecast by Region (2026-2031)
Figure 84. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market ShareForecast by Region (2026-2031)
Figure 85. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market ShareForecast byType (2026-2031)
Figure 86. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market ShareForecast byType (2026-2031)
Figure 87. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market ShareForecast by Application (2026-2031)
Figure 88. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Cytomegalovirus Envelope Glycoprotein B by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Cytomegalovirus Envelope Glycoprotein B by Country/Region, 2020, 2024 & 2031
2.2 Human Cytomegalovirus Envelope Glycoprotein B Segment by Type
2.2.1 CSJ-148
2.2.2 CyMVectin
2.2.3 TRL-345
2.2.4 PPCM
2.2.5 Cytomegalovirus Vaccine
2.2.6 Others
2.3 Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
2.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2020-2025)
2.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Type (2020-2025)
2.4 Human Cytomegalovirus Envelope Glycoprotein B Segment by Application
2.4.1 Infectious Disease
2.4.2 Oncology
2.4.3 Women's Health
2.4.4 Others
2.5 Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
2.5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Market Share by Application (2020-2025)
2.5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Breakdown Data by Company
3.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Company (2020-2025)
3.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2020-2025)
3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Company (2020-2025)
3.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Company (2020-2025)
3.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company (2020-2025)
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Company
3.4 Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Location Distribution
3.4.2 Players Human Cytomegalovirus Envelope Glycoprotein B Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B BY GEOGRAPHIC REGION
4.1 World Historic Human Cytomegalovirus Envelope Glycoprotein B Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country/Region (2020-2025)
4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
4.4 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
4.5 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
4.6 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
5 AMERICAS
5.1 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
5.1.1 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025)
5.1.2 Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025)
5.2 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2020-2025)
5.3 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
6.1.1 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2025)
6.1.2 APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2020-2025)
6.2 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2020-2025)
6.3 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Cytomegalovirus Envelope Glycoprotein B by Country
7.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025)
7.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025)
7.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2020-2025)
7.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B by Country
8.1.1 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2020-2025)
8.3 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B
10.3 Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
10.4 Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors
11.3 Human Cytomegalovirus Envelope Glycoprotein B Customer
12 WORLD FORECAST REVIEW FOR HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B BY GEOGRAPHIC REGION
12.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Region
12.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Region (2026-2031)
12.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Type (2026-2031)
12.7 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Astellas Pharma Inc.
13.1.1 Astellas Pharma Inc. Company Information
13.1.2 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Astellas Pharma Inc. Main Business Overview
13.1.5 Astellas Pharma Inc. Latest Developments
13.2 Trellis Bioscience, Inc.
13.2.1 Trellis Bioscience, Inc. Company Information
13.2.2 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Trellis Bioscience, Inc. Main Business Overview
13.2.5 Trellis Bioscience, Inc. Latest Developments
13.3 Vakzine Projekt Management GmbH
13.3.1 Vakzine Projekt Management GmbH Company Information
13.3.2 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Vakzine Projekt Management GmbH Main Business Overview
13.3.5 Vakzine Projekt Management GmbH Latest Developments
13.4 VBI Vaccine Inc
13.4.1 VBI Vaccine Inc Company Information
13.4.2 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 VBI Vaccine Inc Main Business Overview
13.4.5 VBI Vaccine Inc Latest Developments
13.5 Vical Incorporated
13.5.1 Vical Incorporated Company Information
13.5.2 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Vical Incorporated Main Business Overview
13.5.5 Vical Incorporated Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Human Cytomegalovirus Envelope Glycoprotein B Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Cytomegalovirus Envelope Glycoprotein B Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CSJ-148
Table 4. Major Players of CyMVectin
Table 5. Major Players ofTRL-345
Table 6. Major Players of PPCM
Table 7. Major Players of Cytomegalovirus Vaccine
Table 8. Major Players of Others
Table 9. Global Human Cytomegalovirus Envelope Glycoprotein B Sales byType (2020-2025) & (K Pcs)
Table 10. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share byType (2020-2025)
Table 11. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue byType (2020-2025) & ($ million)
Table 12. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share byType (2020-2025)
Table 13. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price byType (2020-2025) & (USD/Pcs)
Table 14. Global Human Cytomegalovirus Envelope Glycoprotein B Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Market Share by Application (2020-2025)
Table 16. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2020-2025) & ($ million)
Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2020-2025)
Table 18. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2020-2025)
Table 21. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company (2020-2025)
Table 23. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Producing Area Distribution and Sales Area
Table 25. Players Human Cytomegalovirus Envelope Glycoprotein B Products Offered
Table 26. Human Cytomegalovirus Envelope Glycoprotein B Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Geographic Region (2020-2025)
Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country/Region (2020-2025)
Table 35. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2020-2025)
Table 39. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales byType (2020-2025) & (K Pcs)
Table 41. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2020-2025)
Table 44. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales byType (2020-2025) & (K Pcs)
Table 46. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales byType (2020-2025) & (K Pcs)
Table 50. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales byType (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Human Cytomegalovirus Envelope Glycoprotein B
Table 56. Key Market Challenges & Risks of Human Cytomegalovirus Envelope Glycoprotein B
Table 57. Key IndustryTrends of Human Cytomegalovirus Envelope Glycoprotein B
Table 58. Human Cytomegalovirus Envelope Glycoprotein B Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Human Cytomegalovirus Envelope Glycoprotein B Distributors List
Table 61. Human Cytomegalovirus Envelope Glycoprotein B Customer List
Table 62. Global Human Cytomegalovirus Envelope Glycoprotein B SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. Global Human Cytomegalovirus Envelope Glycoprotein B RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Americas Human Cytomegalovirus Envelope Glycoprotein B SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Human Cytomegalovirus Envelope Glycoprotein B Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. APAC Human Cytomegalovirus Envelope Glycoprotein B SalesForecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Human Cytomegalovirus Envelope Glycoprotein B Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 68. Europe Human Cytomegalovirus Envelope Glycoprotein B SalesForecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Human Cytomegalovirus Envelope Glycoprotein B RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B SalesForecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B RevenueForecast by Country (2026-2031) & ($ millions)
Table 72. Global Human Cytomegalovirus Envelope Glycoprotein B SalesForecast byType (2026-2031) & (K Pcs)
Table 73. Global Human Cytomegalovirus Envelope Glycoprotein B RevenueForecast byType (2026-2031) & ($ millions)
Table 74. Global Human Cytomegalovirus Envelope Glycoprotein B SalesForecast by Application (2026-2031) & (K Pcs)
Table 75. Global Human Cytomegalovirus Envelope Glycoprotein B RevenueForecast by Application (2026-2031) & ($ millions)
Table 76. Astellas Pharma Inc. Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 77. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 78. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. Astellas Pharma Inc. Main Business
Table 80. Astellas Pharma Inc. Latest Developments
Table 81.Trellis Bioscience, Inc. Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 82.Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 83.Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84.Trellis Bioscience, Inc. Main Business
Table 85.Trellis Bioscience, Inc. Latest Developments
Table 86. Vakzine Projekt Management GmbH Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 87. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 88. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. Vakzine Projekt Management GmbH Main Business
Table 90. Vakzine Projekt Management GmbH Latest Developments
Table 91. VBI Vaccine Inc Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 92. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 93. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. VBI Vaccine Inc Main Business
Table 95. VBI Vaccine Inc Latest Developments
Table 96. Vical Incorporated Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 97. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 98. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99. Vical Incorporated Main Business
Table 100. Vical Incorporated Latest Developments
LIST OFFIGURES
Figure 1. Picture of Human Cytomegalovirus Envelope Glycoprotein B
Figure 2. Human Cytomegalovirus Envelope Glycoprotein B Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Cytomegalovirus Envelope Glycoprotein B Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country/Region (2024)
Figure 10. Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of CSJ-148
Figure 12. Product Picture of CyMVectin
Figure 13. Product Picture ofTRL-345
Figure 14. Product Picture of PPCM
Figure 15. Product Picture of Cytomegalovirus Vaccine
Figure 16. Product Picture of Others
Figure 17. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share byType in 2025
Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share byType (2020-2025)
Figure 19. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Infectious Disease
Figure 20. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Infectious Disease (2020-2025) & (K Pcs)
Figure 21. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Oncology
Figure 22. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Oncology (2020-2025) & (K Pcs)
Figure 23. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Women's Health
Figure 24. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Women's Health (2020-2025) & (K Pcs)
Figure 25. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Others
Figure 26. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Others (2020-2025) & (K Pcs)
Figure 27. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Market Share by Application (2024)
Figure 28. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application in 2025
Figure 29. Human Cytomegalovirus Envelope Glycoprotein B Sales by Company in 2025 (K Pcs)
Figure 30. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company in 2025
Figure 31. Human Cytomegalovirus Envelope Glycoprotein B Revenue by Company in 2025 ($ millions)
Figure 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company in 2025
Figure 33. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales 2020-2025 (K Pcs)
Figure 36. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue 2020-2025 ($ millions)
Figure 37. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales 2020-2025 (K Pcs)
Figure 38. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue 2020-2025 ($ millions)
Figure 39. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales 2020-2025 (K Pcs)
Figure 40. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales 2020-2025 (K Pcs)
Figure 42. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue 2020-2025 ($ millions)
Figure 43. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2025
Figure 44. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2020-2025)
Figure 45. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share byType (2020-2025)
Figure 46. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
Figure 47. United States Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region in 2025
Figure 52. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2020-2025)
Figure 53. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share byType (2020-2025)
Figure 54. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
Figure 55. China Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 59. India Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 61. ChinaTaiwan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2025
Figure 63. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2020-2025)
Figure 64. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share byType (2020-2025)
Figure 65. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
Figure 66. Germany Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 67.France Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share byType (2020-2025)
Figure 73. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
Figure 74. Egypt Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 77.Turkey Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B in 2025
Figure 80. Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
Figure 81. Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B
Figure 82. Channels of Distribution
Figure 83. Global Human Cytomegalovirus Envelope Glycoprotein B Sales MarketForecast by Region (2026-2031)
Figure 84. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market ShareForecast by Region (2026-2031)
Figure 85. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market ShareForecast byType (2026-2031)
Figure 86. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market ShareForecast byType (2026-2031)
Figure 87. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market ShareForecast by Application (2026-2031)
Figure 88. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Hexanoic Acid Market Growth 2025-2031
US$ 3,660.00
December 2024
98 pages
Global Liquid Waxes Market Growth 2024-2030
US$ 3,660.00
March 2024
135 pages
Global Rare Earth Magnet for EPS Market Growth 2024-2030
US$ 3,660.00
June 2024
95 pages
Global Boswellia Serrata Extract Market Growth 2025-2031
US$ 3,660.00
September 2025
92 pages
Global Enzyme for Baking Market Growth 2024-2030
US$ 3,660.00
August 2024
113 pages
